ArticleJACC. Case reports2025
Rescuing Protamine Anaphylaxis Refractory to Adrenaline Using Extracorporeal Membrane Oxygenation.
Article in JACC. Case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Protamine is widely used after catheter ablation to achieve hemostasis. Anaphylaxis to protamine is a rare but severe complication. A 49-year-old male patient underwent catheter ablation of symptomatic long-standing persistent atrial fibrillation. Sinus bradycardia emerged 20 minutes after the protamine infusion and was unresponsive to atropine. Subsequently, pulseless electrical activity and severe global hypokinesis developed and were refractory to pacing and repeated infusions of intravenous adrenaline. Extracorporeal membrane oxygenation and a catecholamine infusion were required for the following 2 days. An intradermal test with protamine showed positive results, and adrenaline-refractory anaphylaxis (ARA) was diagnosed. The incidence of protamine anaphylaxis is 0.14%, and ARA may occur, especially in patients receiving beta-blockers. Although there is no established approach, glucagon, methylene blue, and the rapid introduction of extracorporeal membrane oxygenation should be considered when ARA is suspected.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.